identifiers.org/ega.study:EGAS00001004899

Preview meta tags from the identifiers.org website.

Linked Hostnames

11

Thumbnail

Search Engine Appearance

Google

https://identifiers.org/ega.study:EGAS00001004899

Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor - EGA European Genome-Phenome Archive

The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy. Tre...



Bing

Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor - EGA European Genome-Phenome Archive

https://identifiers.org/ega.study:EGAS00001004899

The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy. Tre...



DuckDuckGo

https://identifiers.org/ega.study:EGAS00001004899

Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor - EGA European Genome-Phenome Archive

The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy. Tre...

  • General Meta Tags

    6
    • title
      Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor - EGA European Genome-Phenome Archive
    • description
      The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy. Tre...
    • charset
      utf-8
    • viewport
      width=device-width, initial-scale=1.0
    • X-UA-Compatible
      IE=edge

  • Open Graph Meta Tags

    3
    • og:title
      Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor - EGA European Genome-Phenome Archive
    • og:description
      The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy. Tre...
    • og:image
      https://static.ega-archive.org/img/social_media_logo.png

  • Link Tags

    5
    • icon
      https://static.ega-archive.org/img/favicon.ico
    • stylesheet
      https://static.ega-archive.org/css/studies.css
    • stylesheet
      https://static.ega-archive.org/css/responsive_small.css
    • stylesheet
      https://static.ega-archive.org/css/responsive_medium.css
    • stylesheet
      https://static.ega-archive.org/css/responsive_large.css

Links

57